Clonal hematopoiesis of indeterminate potential and atrial fibrillation DOI
Jie Liu,

Nan Zhang,

Guangshuai Teng

et al.

Heart Rhythm, Journal Year: 2025, Volume and Issue: unknown

Published: May 1, 2025

Language: Английский

Inflammasomes and Atherosclerosis: a Mixed Picture DOI Open Access
Alan R. Tall, Karin Bornfeldt

Circulation Research, Journal Year: 2023, Volume and Issue: 132(11), P. 1505 - 1520

Published: May 25, 2023

The CANTOS (Canakinumab Anti-inflammatory Thrombosis Outcome Study) and colchicine trials suggest an important role of inflammasomes their major product IL-1β (interleukin 1β) in human atherosclerotic cardiovascular disease. Moreover, studies mouse models indicate a causal atherosclerosis. However, recent have led to more granular view the Studies hyperlipidemic that prominent activation NLRP3 inflammasome requires second hit such as defective cholesterol efflux, DNA repair, clonal hematopoiesis or diabetes. Similarly humans some mutations promoting increase coronary artery disease risk part by activation. Recent mice point wider AIM2 (absent melanoma 2) including forms These developments precision medicine approach which treatments targeting might be best employed clinical settings involving increased

Language: Английский

Citations

45

DNMT3A clonal hematopoiesis-driver mutations induce cardiac fibrosis by paracrine activation of fibroblasts DOI Creative Commons
Mariana Shumliakivska, Guillermo Luxán,

Inga Hemmerling

et al.

Nature Communications, Journal Year: 2024, Volume and Issue: 15(1)

Published: Jan. 19, 2024

Hematopoietic mutations in epigenetic regulators like DNA methyltransferase 3 alpha (DNMT3A), play a pivotal role driving clonal hematopoiesis of indeterminate potential (CHIP), and are associated with unfavorable outcomes patients suffering from heart failure (HF). However, the precise interactions between CHIP-mutated cells other cardiac cell types remain unknown. Here, we identify fibroblasts as partners monocytes. We used combined transcriptomic data derived peripheral blood mononuclear HF patients, both without CHIP, tissue. demonstrate that inactivation DNMT3A macrophages intensifies increases fibrosis. amplifies release heparin-binding epidermal growth factor-like factor, thereby facilitating activation fibroblasts. These findings pathway CHIP-driver to initiation progression may also provide compelling basis for development innovative anti-fibrotic strategies.

Language: Английский

Citations

31

Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction DOI Open Access
Jesse D. Cochran, Yoshimitsu Yura, Mark C. Thel

et al.

Circulation, Journal Year: 2023, Volume and Issue: 148(15), P. 1165 - 1178

Published: Sept. 8, 2023

Clonal hematopoiesis (CH), which results from an array of nonmalignant driver gene mutations, can lead to altered immune cell function and chronic disease, has been associated with worse outcomes in patients heart failure (HF) reduced ejection fraction. However, the role CH prognosis HF preserved fraction (HFpEF) understudied. This study aimed characterize HFpEF elucidate its causal a murine model.

Language: Английский

Citations

33

Hematopoietic Stem Cells and the Immune System in Development and Aging DOI Open Access
Daniil Shevyrev, Valeriy Tereshchenko, Tatiana Berezina

et al.

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(6), P. 5862 - 5862

Published: March 20, 2023

Hematopoietic stem cells (HSCs) support haematopoiesis throughout life and give rise to the whole variety of immune system. Developing in early embryo, passing through precursor stage, maturing into first HSCs, they undergo a fairly large number divisions while maintaining high regenerative potential due repair activity. This is greatly reduced adult HSCs. They go state dormancy anaerobic metabolism maintain their stemness life. However, with age, changes occur pool HSCs that negatively affect effectiveness immunity. Niche aging accumulation mutations age reduces ability self-renew differentiation potential. accompanied by decrease clonal diversity disturbance lymphopoiesis (decrease formation naive T- B-cells) predominance myeloid haematopoiesis. Aging also affects mature cells, regardless HSC, therefore, phagocytic activity intensity oxidative burst decrease, efficiency processing presentation antigens impaired. innate adaptive immunity produce factors form chronic inflammatory background. All these processes have serious negative impact on protective properties system, increasing inflammation, risk developing autoimmune, oncological, cardiovascular diseases age. Understanding mechanisms reducing comparative analysis embryonic features will allow us get closer deciphering programs for development, aging, regeneration rejuvenation

Language: Английский

Citations

27

Toward Heart-Healthy and Sustainable Cities: A Policy Statement From the American Heart Association DOI Creative Commons
Sanjay Rajagopalan, Anu Ramaswami, Aruni Bhatnagar

et al.

Circulation, Journal Year: 2024, Volume and Issue: 149(15)

Published: March 4, 2024

Nearly 56% of the global population lives in cities, with this number expected to increase 6.6 billion or >70% world's by 2050. Given that cardiometabolic diseases are leading causes morbidity and mortality people living urban areas, transforming cities provisioning systems (or systems) toward health, equity, economic productivity can enable dual attainment climate health goals. Seven provide food, energy, mobility-connectivity, housing, green infrastructure, water management, waste management lie at core human well-being, sustainability. These transcend city boundaries (eg, demand for water, energy is met transboundary supply); thus, entire system a larger construct than local environments. Poorly designed starkly evident worldwide, resulting unprecedented exposures adverse risk factors, including limited physical activity, lack access heart-healthy diets, reduced greenery beneficial social interactions. Transforming health-first approach could be accomplished through integrated spatial planning, along addressing current gaps key systems. Such an will help mitigate undesirable environmental improve cardiovascular metabolic while improving planetary health. The purposes American Heart Association policy statement present conceptual framework, summarize evidence base, outline principles heart-health sustainability outcomes.

Language: Английский

Citations

14

Experimental TET2 Clonal Hematopoiesis Predisposes to Renal Hypertension Through an Inflammasome-Mediated Mechanism DOI
Ariel H. Polizio, Lucila Marino, Kyung‐Duk Min

et al.

Circulation Research, Journal Year: 2024, Volume and Issue: 135(9), P. 933 - 950

Published: Sept. 5, 2024

BACKGROUND: Hypertension incidence increases with age and represents one of the most prevalent risk factors for cardiovascular disease. Clonal events in hematopoietic system resulting from somatic mutations driver genes are elderly individuals who lack overt hematologic disorders. This condition is referred to as age-related clonal hematopoiesis (CH), it a newly recognized factor It not known whether CH hypertension causally related and, if so, what mechanistic features. METHODS: A murine model adoptive bone marrow transplantation was employed examine interplay between Tet2 (ten-eleven translocation methylcytosine dioxygenase 2) hypertension. RESULTS: In this model, subpressor dose Ang II (angiotensin II) resulted elevated systolic diastolic blood pressure early 1 day after challenge. These conditions led expansion Tet2-deficient proinflammatory monocytes progenitor populations. deficiency promoted renal CCL5 (C-C motif ligand 5) chemokine expression macrophage infiltration into kidney. Consistent involvement, myeloid cells when mice were treated II. The −/− sodium retention, inflammasome activation, levels IL (interleukin)-1β IL-18. Analysis transporters indicated NCC (sodium-chloride symporter) NKCC2 (Na + -K -Cl − cotransporter activation at residues Thr53 Ser105, respectively. Administration NLRP3 (NLR family pyrin domain containing 3) inhibitor MCC950 reversed hypertensive state, transporter activation. CONCLUSIONS: Tet2-mediated sensitizes stimulus. Mechanistically, promotes due immune cell inflammasome, consequences on retention. data indicate that carriers TET2 could be development modulators useful treating patient population.

Language: Английский

Citations

10

Loss of the Y chromosome in coronary artery disease DOI Creative Commons
Soichi Sano, Kenneth Walsh

European Heart Journal, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 28, 2025

Graphical AbstractLoss of the Y chromosome (LOY) in blood accelerates progression cardiovascular disease patients with coronary artery (CAD). Weyrich et al. analysed samples from male CAD and found that those >17% LOY white cells had an increased risk mortality fatal myocardial infarction. The authors further observed immune exhibited decreased expression RPS5, serum higher levels contained elevated proinflammatory profibrotic molecules. Additionally, culture supernatant RPS5-knockdown THP-1 was shown to activate human cardiac fibroblasts, inducing their transition a more myofibroblast phenotype.Open new tabDownload slide

Language: Английский

Citations

1

Single-cell multi-scale footprinting reveals the modular organization of DNA regulatory elements DOI Creative Commons
Yan Hu, Sai Ma, Vinay K. Kartha

et al.

bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2023, Volume and Issue: unknown

Published: March 29, 2023

-regulatory elements control gene expression and are dynamic in their structure, reflecting changes to the composition of diverse effector proteins over time

Language: Английский

Citations

20

Association Between Clonal Hematopoiesis and Left Ventricular Reverse Remodeling in Nonischemic Dilated Cardiomyopathy DOI Creative Commons
Shunsuke Inoue, Toshiyuki Ko, Akito Shindo

et al.

JACC Basic to Translational Science, Journal Year: 2024, Volume and Issue: 9(8), P. 956 - 967

Published: June 13, 2024

Although clonal hematopoiesis of indeterminate potential (CHIP) is an adverse prognostic factor for atherosclerotic disease, its impact on nonischemic dilated cardiomyopathy (DCM) elusive. The authors performed whole-exome sequencing and deep target among 198 patients with DCM detected germline mutations in cardiomyopathy-related genes somatic CHIP driver genes. Twenty-five were 22 DCM. Ninety-two had pathogenic mutations. Multivariable analysis revealed that was independent risk left ventricular reverse remodeling, irrespective known factors. exacerbated cardiac systolic dysfunction fibrosis a murine model. identification predicts clinical prognosis.

Language: Английский

Citations

7

Clonal Hematopoiesis: Connecting Aging and Inflammation in Atherosclerosis DOI
Ariel H. Polizio, Eunbee Park, Kenneth Walsh

et al.

Current Atherosclerosis Reports, Journal Year: 2023, Volume and Issue: 25(3), P. 105 - 111

Published: Feb. 18, 2023

Language: Английский

Citations

15